Press "Enter" to skip to content

Top Headline

  • AVCO could be the next Big Biotech in the NASDAQ Roundtable as $JAZZ signs Licensing agreement with $HOWL Today: Can $AVCO a Leading global developer of cell-based Technologies & Therapeutics be next?

    Werewolf Therapeutics Inc. $HOWL shares rose 26% Thursday after the company signed a licensing agreement with Jazz Pharmaceuticals PLC $JAZZ worth up to $1.2 billion..…

    Read More